INTELLIA THERAPEUTICS INC (NTLA) Stock Cash Flow
NASDAQ:NTLA - Nasdaq - US45826J1051 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -522.28M | -481.19M | -474.19M | -267.89M | -134.23M | |||
| Depreciation Amortization | 10.19M | 8.98M | 7.57M | 6.89M | 6.31M | |||
| Change In Working Capital | 12.95M | -52.45M | -53.87M | -22.90M | 57.53M | |||
| Other non cash items | 142.41M | 130.58M | 187.20M | 58.88M | 20.48M | |||
| OPERATING CASH FLOW | -356.74M | -394.09M | -333.29M | -225.03M | -49.91M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -6.31M | -13.98M | -13.56M | -12.76M | -3.59M | |||
| Other Investing Activity | 26.26M | -17.36M | 173.87M | -538.02M | -210.90M | |||
| INVESTING CASH FLOW | 19.95M | -31.35M | 160.31M | -550.78M | -214.49M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 289.91M | 130.32M | 582.96M | 736.69M | 371.78M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 289.91M | 130.32M | 582.96M | 736.69M | 371.78M | |||
| CHANGE IN CASH | -46.88M | -295.11M | 409.98M | -39.12M | 107.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -356.74M | -394.09M | -333.29M | -225.03M | -49.91M | |||
| Capital Expenditure | -6.31M | -13.98M | -13.56M | -12.76M | -3.59M | |||
| FREE CASH FLOW | -363.05M | -408.07M | -346.85M | -237.79M | -53.50M | |||
All data in USD